Warning: Undefined variable $insensitive in /home/u792129758/domains/sciencefather.com/public_html/mechanics-conferences/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 201
Warning: Undefined variable $insensitive in /home/u792129758/domains/sciencefather.com/public_html/mechanics-conferences/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 202
Assoc. Prof. Dr A F M Motiur Rahman | liquidos ionicos | Best Researcher Award
Associate Professor at Pharmaceutical Chemistry, Saudi Arabia
A dedicated pharmaceutical scientist, Assoc. Prof. Dr A F M Motiur Rahman holds a Ph.D. from Yeungnam University, South Korea, with a strong foundation in medicinal chemistry, particularly in synthetic molecule design and drug metabolism. Serving as an Associate Professor at King Saud University, Saudi Arabia, he leads research in synthetic molecule development for anticancer applications, mentoring students across various academic levels. His work encompasses innovative synthesis and bio-conjugate chemistry, advancing cancer drug discovery through ongoing projects and published articles.
Publication Profile
DNA-binding and Anticancer Research
Title: Exploring the DNA-binding and anticancer potential of polypyridyl ruthenium(II) complexes
Journal: Journal of Molecular Structure, 2025, 1321, Article 140044
Authors: Zhang, D., Li, M., Rahman, A.F.M.M., Liu, Z., Lu, Y.
Citations: 0
Multitarget Anticancer Agents
Title: Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents
Journal: ACS Omega, 2024, 9(40), Pages 41944β41967
Authors: Saadan, N.M., Ahmed, W.U., Kadi, A.A., Al-Wabli, R.I., Rahman, A.F.M.M.
Citations: 0
Dual Inhibition in Cancer Therapy
Title: Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2
Journal: Journal of Molecular Structure, 2024, 1309, Article 138177
Authors: Mirgany, T.O., Rahman, A.F.M.M., Alanazi, M.M.
Citations: 1
Antibacterial Compound Discovery
Title: New antibacterial penicimenolide G with unusual 12-membered resorcylic acid lactone ring isolated from Aspergillus giganteus
Journal: Phytochemistry Letters, 2024, 62, Pages 18β23
Authors: Shamim, A.H.M., Mondol, M.A.M., Hossain, M., Alharbi, H.A., Rahman, A.F.M.M.
Citations: 0
Multi-Kinase Inhibitors Development
Title: Discovery of 1H-benzo[d]imidazole-(halogenated)benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors
Journal: Pharmaceuticals, 2024, 17(7), Article 839
Authors: Mirgany, T.O., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.
Citations: 0
Anticancer Photophysical Studies
Title: Synthesis, Cytotoxicity, and Photophysical Investigations of 2-Amino-4,6-diphenylnicotinonitriles
Journal: Molecules, 2024, 29(8), Article 1808
Authors: Al-Ghamdi, A.R., Rahman, S., Al-Wabli, R.I., Al-Mutairi, M.S., Rahman, A.F.M.M.
Citations: 0
Solar Cell Efficiency
Title: The photon-electrical conversion efficiency of dye-sensitive solar cells fabricated using silver-nanoparticle/titania photocathode
Journal: Applied Research, 2024, 3(1), Article e202300044
Authors: Daniel, L.S., Kaffer, R.T., Kalipi, L.M., Kalengay, M., Uahengo, V.
Citations: 0
Nano Drug Delivery System for Brain
Title: Phospholipid-based nano drug delivery system of curcumin using MSP1D1 protein and poloxamer 407
Journal: Journal of Nanoparticle Research, 2024, 26(1), Article 12
Authors: Shariare, M.H., Mannan, M., Khan, F., Uddin, M.N., Kazi, M.
Citations: 2
Pyrrolo[2,3-d]pyrimidine Kinase Inhibitors
Title: Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers
Journal: Pharmaceuticals, 2023, 16(9), Article 1324
Authors: Alotaibi, A.A., Alanazi, M.M., Rahman, A.F.M.M.
Citations: 4
Selective Kinase Inhibition
Title: Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity
Journal: Journal of Saudi Chemical Society, 2023, 27(5), Article 101712
Authors: Alotaibi, A.A., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.
Citations: 10
Conclusion
Given the candidateβs robust academic qualifications, international research experience, successful mentorship, and strong track record in pharmaceutical and organic chemistry research, they are exceptionally suited for the Best Researcher Award. Their commitment to teaching, funding acquisition, and contributions to therapeutic compound development mark them as a distinguished researcher who has made impactful contributions to the field. Further engagement in publishing and interdisciplinary initiatives could enhance their already strong candidacy, positioning them as a future leader in pharmaceutical chemistry and organic synthesis.